B. Wang et al.
13C NMR (CDCl3): d=176.6, 175.3, 148.7, 141.3, 139.3, 137.8, 134.5,
133.9, 131.4, 128.8, 128.4, 127.2, 125.9, 125.1, 123.3, 120.8, 115.6, 114.5,
111.3, 105.2, 55.5 (OCH3), 43.4 (CH2), 29.7 ppm (CH2); MS (ESI): m/z
(%): 500.9 [MꢀH]+, 501.8 [M+], 502.8 [M+H]+, 503.8 [M+2H]+.
3-[(2-Benzyl-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-ylamino)-
methyl]-4-bromobenzoic acid methyl ester (6c): Column chromatography
(hexanes/ethyl acetate 8:1) gave 6c (25%) as a yellow powder. TLC
(hexanes/ethyl acetate 1:2): Rf =0.45; 1H NMR (CDCl3): d=8.65 (d, J=
.0 Hz, 1H), 8.48 (d, J=8.4 Hz, 1H), 8.18 (d, J=7.6 Hz, 1H), 8.07 (s, 1H),
7.89 (m, J=8.4 Hz, 1H), 7.76 (d, J=8.4 Hz, 1H), 7.69 (t, J=7.6 Hz, 1H),
7.55 (d, J=6.8 Hz, 2H), 7.23 (m, 3H), 6.71 (d, J=8.4 Hz, 1H), 5.39 (s,
2H; CH2), 4.77 (s, 2H; CH2), 3.88 ppm (s, 3H; CH3); MS (ESI): m/z
(%): 529.0 [M+], 531.0 [M+2H]+.
(1a–d) will be very useful for the preparation of long-wave-
length sensors and boronolectins[29] for carbohydrates, glyco-
lipids, and glycoproteins. Work on incorporating these bor-
onic acids into DNA for fluorescent aptamer development
is in progress.[85]
Experimental Section
General: 1H and 13C NMR spectra were recorded on a Bruker 400 MHz
spectrophotometer in deuterated choloroform (CDCl3) or deuterated
[D6]DMSO ((CD3)2SO) with either tetramethylsilane (TMS; d=
0.00 ppm) or the NMR solvent as the internal reference unless otherwise
specified. HPLC purification was carried out with a Shimadzu LC-10AT
VP system and a Zobax C18 reversed-phase column (4.6 mm25 cm).
Fluorescence spectra were recorded on a Shimadzu RF-5301 PC spectro-
fluorometer. Absorption spectra were recorded on a Shimadzu UV-1700
UV/Vis spectrophotometer. Quartz cuvettes were used in all fluorescence
and UV studies. All pH values were determined by a UB-10 Ultra basic
benchtoppH meter (Denver Instruments). Analytical thin-layer chroma-
tography (TLC) was performed on Merck silica gel 60 plates (0.25 mm
thickness with F-254 indicator). Sugars, buffers, and diols were bought
from Aldrich or Acros and were used as received. Water used for the
binding studies was doubly distilled and further purified with a Milli-Q
filtration system. Solvents for extraction and chromatography were used
as received. Drying solvents (DMF, DMSO) were purchased from Acros.
1H, 13C NMR and MS spectra of selected compounds are given in the
Supporting Information.
2-Benzyl-6-(2-bromo-5-fluorobenzylamino)-benzo[de]isoquinoline-1,3-
dione (6d): Column chromatography (hexanes/ethyl acetate 12:1) gave
6d (27%) as a yellow powder. TLC (hexanes/ethyl acetate 1:2): Rf =0.50;
1H NMR ([D6]acetone, 400 MHz): d=8.72 (d, J=8.4 Hz, 1H), 8.57 (d,
J=7.2 Hz, 1H), 8.37 (d, J=8.4 Hz, 1H), 7.79–7.72 (m, 3H), 7.46 (d, J=
7.2 Hz, 2H), 7.31–7.20 (m, 4H), 7.11–7.06 (m, 1H), 6.71 (d, J=8.4 Hz,
1H), 5.33 (s, 2H; CH2), 4.81 ppm (s, 2H; CH2); 13C NMR ([D6]acetone):
d=178.2, 176.4, 163.3, 149.7, 138.4, 134.5, 134.1, 130.9, 128.2, 127.6, 126.9,
124.9, 120.8, 116.0, 115.7, 110.4, 104.8, 47.2 (CH2), 42.7 ppm (CH2); MS
(ESI): m/z (%): 489.0 [M+], 490.1 [M+H]+.
General procedure for synthesis of compounds 1: According to a typical
borylation procedure,
borane (64.2 mg, 0.284 mmol, 1.2 equiv), [PdCl2
6
(0.237 mmol, 1.0 equiv), bis(neopentylglycol)
(dppf)] (23.5 mg,
AHCTREUNG
0.029 mmol, 0.12 equiv), and potassium acetate (70.5 mg, 0.718 mmol,
3 equiv) were mixed at room temperature under an N2 atmosphere. This
was followed by addition of anhydrous DMSO (2 mL) with a syringe.
The solution was heated at 908C for 10 h and then cooled to room tem-
perature. Ethyl acetate (20 mL) and water (15 mL) were added to the re-
action mixture. The separated organic phase was washed with water (2
10 mL). After drying over sodium sulfate and solvent evaporation, the
residue was purified by column chromatography (hexanes/ethyl acetate
3:2, to ethyl acetate/methanol 10:1) and further purified by HPLC (C18
RP column). Elution conditions: CH3CN/MeOH (1 mLminꢀ1); 0–10 min
(CH3CN 100%), 10–20 min (CH3CN 100!0%), 20–29 min (CH3CN
0%), 29–30 min (CH3CN 0!100%).
2-Benzyl-6-(2-boronic acid-5-methoxy-benzylamino)-benzo[de]isoquino-
line-1,3-dione (1b): 1b (24%) was obtained as a red powder. HPLC: tR =
20 min; 1H NMR (CD3OD, 400 MHz): d=8.22 (d, J=7.2 Hz, 1H), 8.05
(d, J=8.4 Hz, 1H), 7.59 (d, J=6.8 Hz, 1H), 7.35 (d, J=8.4 Hz, 2H),
7.17–7.27 (m, 4H), 7.02 (d, J=7.6 Hz, 2H), 6.74 (t, J=10.8 Hz, 1H), 6.17
(d, J=8.4 Hz, 1H), 5.33 (s, 2H; CH2), 4.52 (s, 2H; CH2), 3.73 ppm (s,
3H; CH3); 13C NMR (CD3OD): d=166.3, 164.6, 163.2, 159.8, 141.8,
138.6, 137.3, 132.0, 129.3, 128.7, 127.8, 127.6, 127.2, 126.3, 124.8, 119.6,
117.9, 112.5, 111.8, 102.3, 100.3, 54.2 (OCH3), 46.3 (CH2), 42.5 ppm
(CH2); MS (ESI): m/z (%): 466.2 [M+], 467.2 [M+H]+, 468.2 [M+2H]+.
General procedure for synthesis of compounds 5: Dry CCl4 (100 mL) was
added to
a mixture of 4 (10 mmol, 1.0 equiv), AIBN (0.5 mmol,
0.05 equiv), and NBS (10 mmol, 1.0 equiv). The mixture was heated at
708C (reflux) under white light (IR: 115–125 V, 175 W) with stirring for
2.5 h. Then solvent was evaporated under vacuum.
4-Bromo-3-bromomethylbenzoic acid methyl ester (5c): Column chroma-
tography (hexanes/ethyl acetate 8:1) gave 5c (38%) as white crystals.
TLC (hexanes/ethyl acetate 10:1): Rf =0.50; 1H NMR (CDCl3): d=8.08
(s, 1H), 7.77 (t, J=8.4 Hz, 1H), 7.62 (d, J=8.4 Hz, 1H), 4.58 (s, 2H;
CH2), 3.89 ppm (s, 3H; CH3); 13C NMR (CDCl3): d=165.8, 137.5, 133.6,
132.2, 130.8, 130.1, 129.8 (COOCH3), 52.5 (OCH3), 32.6 ppm (CH2); MS
(ESI): m/z (%): 310 [M+].
1-Bromo-2-bromomethyl-4-fluorobenzene (5d): Column chromatography
(hexanes) gave 5d (39%) as white crystals. TLC (hexanes/ethyl acetate
10:1): Rf =0.50; 1H NMR (CDCl3): d=7.48–7.52 (m, 1H), 7.16–7.19 (m,
1H), 6.86–6.91 (m, 1H), 4.52 ppm (s, 2H; CH2); 13C NMR (CDCl3): d=
163.1, 160.6, 138.9, 134.5, 118.1, 117.3, 32.5 ppm (CH2); MS (ESI): m/z
(%): 268 [M+], 270 [M+2H]+.
1-Bromo-2-bromomethyl-4-nitrobenzene (5e): Column chromatography
(hexanes/ethyl acetate 20:1) gave 5e (21%) as white crystals. TLC (hex-
anes/ethyl acetate 20:1): Rf =0.50; 1H NMR (CDCl3): d=8.31 (s, 1H),
8.00 (m, J=11.6 Hz, 1H), 7.76 (d, J=8.4 Hz, 1H), 4.61 ppm (s, 2H;
CH2); 13C NMR (CDCl3): d=139.0, 134.5 (2C), 131.6, 125.9, 124.4,
31.5 ppm (CH2); MS (ESI): m/z (%): 295 [M+], 297 [M+2H]+.
3-[(2-Benzyl-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-ylamino)-
methyl]-4-boronic acid-benzoic acid methyl ester (1c): 1c (14%) was ob-
tained as a red powder. HPLC: tR =22 min; 1H NMR (CD3OD): d=8.25
(d, J=6.8 Hz, 1H), 8.15 (s, 1H), 8.08 (d, J=8.4 Hz, 1H), 7.88 (d, J=
7.2 Hz, 1H), 7.72 (d, J=8.0 Hz, 1H), 7.62 (d, J=6.8 Hz, 1H), 7.36–7.43
(m, 3H), 7.26–7.29 (m, 2H), 7.20 (d, J=8.8 Hz, 1H), 6.18 (d, J=8.8 Hz,
1H), 5.35 (s, 2H; CH2), 4.62 (s, 2H; CH2), 3.88 ppm (s, 3H; CH3); MS
(ESI): m/z (%): 493.1 [MꢀH]+, 495.1 [M+H]+, 522.1 [Mꢀ2H+2CH3]+.
General procedure for synthesis of compounds 6: Dry DMF (25 mL) was
added to a mixture of 3 (1.00 mmol, 1.0 equiv) and sodium hydride
(60%, 1.03 mmol, 1.03 equiv). The mixture was stirred for 10 min, then a
solution of 5 (1.00 mmol, 1.0 equiv) in anhydrous DMF (15 mL) was
added dropwise under N2 at room temperature with stirring. Afterwards,
the stirring was continued at room temperature for 12 h. The solvent was
then evaporated under vacuum.
2-Benzyl-6-(2-boronic acid-5-fluorobenzylamino)-benzo[de]isoquinoline-
1,3-dione (1d): 1d (21%) was obtained as a red powder. HPLC: tR
=
21 min; 1H NMR (CD3OD, 400 MHz): d=8.55 (d, J=7.2 Hz, 1H), 8.47
(d, J=8.4 Hz, 1H), 7.66 (d, J=7.6 Hz, 1H), 7.42–7.48 (m, 3H), 7.21–7.37
(m, 6H), 7.07–7.14 (m, 2H), 5.35 (s, 2H; CH2), 4.55 ppm (s, 2H; CH2);
13C NMR (CD3OD): d=174.0, 164.7, 164.2, 140.5, 137.67, 133.8, 130.12,
128.4, 128.0, 127.7, 126.8, 124.0, 123.0, 122.3, 114.4, 110.5, 107.4, 104.9,
48.3 (CH2), 42.8 ppm (CH2); MS (ESI): m/z (%): 453.1 [MꢀH]+, 454.1
[M+].
2-Benzyl-6-(2-bromo-5-methoxybenzylamino)-benzo[de]isoquinoline-1,3-
dione (6b): Column chromatography (hexanes/ethyl acetate 12:1) gave
6b (31%) as a yellow powder. TLC (hexanes/ethyl acetate 1:2): Rf =0.50;
1H NMR (CDCl3): d=8.64 (d, J=6.4 Hz, 1H), 8.49 (d, J=8.4 Hz, 1H),
8.10 (d, J=8.4 Hz, 1H), 7.61–7.64 (m, 1H), 7.49–7.52 (m, 3H), 7.26–7.28
(m, 2H), 7.21 (d, J=7.2 Hz, 1H), 6.91 (d, J=4.2 Hz, 1H), 6.68–6.75 (m,
2H), 5.35 (s, 2H; CH2), 4.63 (s, 2H; CH2), 3.70 ppm (s, 3H; CH3);
Procedures for the binding studies (with 1a as an example): Solutions of
1a (110ꢀ5 m) and 1a (110ꢀ5 m) with sugar (0.5m) were prepared in
0.1m phosphate buffer at pH 7.40. These two solutions were then mixed
2802
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2008, 14, 2795 – 2804